Clinical Trials in North Carolina

Showing 9081-9100 of 15,496 trials

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

NCT03654313

To evaluate the safety, tolerability, PK and immunogenicity of single and multiple ascending doses of MEDI6570 in subjects with Type 2 Diabetes Mellitus

AtherosclerosisCardiovascular Disease

MedImmune LLC88 participantsStarted Sep 2018

Anniston, Alabama, United States • Jacksonville, Florida, United States • Miami, Florida, United States +6 more locations

COMPLETEDPhase 325 miles

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

NCT03731091

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064% (Glenmark Pharmaceuticals Ltd) to the Marketed Product Enstilar® Foam (LEO Pharma Inc.) in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis)

Psoriasis Vulgaris

Glenmark Pharmaceuticals Ltd. India494 participantsStarted Oct 2018

Encinitas, California, United States • Fountain Valley, California, United States • San Diego, California, United States +27 more locations

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

Find Trials by Condition in North Carolina

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Buproprion for Binge Drinking

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP)

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence